Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Recent Tweets

$LLY Lilly to share Phase 3 EMBER-3 study results of Imlunestrant, an oral SERD, and more breast cancer portfolio findings at San Antonio Breast Cancer Symposium.

More Info: https://pryzm.ozmosi.com/product/21349 $XBI $IBB $XPH $PPH

$OKUR OnKure will share clinical and preclinical data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium.

More Info: https://pryzm.ozmosi.com/product/32458 $XBI $IBB $XPH $PPH

$IRON Disc Medicine will host a conference call to discuss the End of Phase 2 FDA meeting for Bitopertin in Erythropoietic Protoporphyria (EPP).

More Info: https://pryzm.ozmosi.com/product/269 $XBI $IBB $XPH $PPH

$ADTX, APLIF, EVFM, TSX:APLI Aditxt's Target Acquisition Appili Therapeutics aligns with FDA on ATI-1801 topical antiparasitic NDA submission requirements.

More Info: https://pryzm.ozmosi.com/product/30228 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762